U.S. Markets closed

Protagonist Therapeutics posts 4Q loss

MALPITAS, Calif. (AP) _ Protagonist Therapeutics Inc. (PTGX) on Tuesday reported a loss of $11.2 million in its fourth quarter.

On a per-share basis, the Malpitas, California-based company said it had a loss of 67 cents.

For the year, the company reported a loss of $37.7 million, or $5.80 per share.

Protagonist Therapeutics shares have declined 39 percent since the beginning of the year.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTGX at https://www.zacks.com/ap/PTGX


Keywords: Protagonist Therapeutics, Earnings Report